Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1995
12/26/1995US5478827 Pyrazole derivatives
12/26/1995US5478821 Method of accelerating the proliferation of emdothelial cells with inhibition of no synthases
12/26/1995US5478573 Delayed, sustained-release propranolol pharmaceutical preparation
12/26/1995CA2028746C Pharmaceutical compositions and methods for treating the symptoms of overindulgence
12/26/1995CA2004534C Metallo-organic compounds and uses thereof
12/21/1995WO1995034671A1 Complementary adenoviral vector systems and cell lines
12/21/1995WO1995034659A1 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
12/21/1995WO1995034652A1 Calcium binding recombinant antibody against protein c
12/21/1995WO1995034566A1 Lactam inhibitors of cholesterol esterase
12/21/1995WO1995034564A1 Pirydyl imidazole derivatives and processes for the preparation thereof
12/21/1995WO1995034563A1 Pyrazolo and pyrrolopyridines
12/21/1995WO1995034561A1 Benzoylecgonine, ecgonine and ecgonidine derivatives
12/21/1995WO1995034555A1 Benzimidazolone derivatives with central dopaminergic activity
12/21/1995WO1995034540A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
12/21/1995WO1995034535A1 Novel farnesyl transferase inhibitors, their preparation and pharmaceutical compositions containing same
12/21/1995WO1995034534A1 Enzyme inhibitors
12/21/1995WO1995034324A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
12/21/1995WO1995034300A1 Process for the preparation of acanthoic acid and pharmaceutical composition comprising same
12/21/1995WO1995034280A1 Methods of lightening hyperpigmented regions in mammalian skin
12/21/1995WO1995018616A3 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor
12/21/1995CA2192984A1 Lactam inhibitors of cholesterol esterase
12/21/1995CA2192668A1 Amidino sulfone derivatives for use as inos inhibitors claims
12/21/1995CA2192389A1 Novel farnesyl transferase inhibitors, their preparation and pharmaceutical compositions containing same
12/21/1995CA2191870A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
12/21/1995CA2190611A1 Covalently coupled benzoylecgonine, ecgonine and ecgonidine derivatives
12/20/1995EP0687675A2 Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof
12/20/1995EP0687470A2 Agents for treating metabolic bone diseases
12/20/1995EP0687468A2 Pharmaceutical composition for suppressing infiltration of eosinophils
12/20/1995EP0687270A1 Osteogenic growth oligopeptides and pharmaceutical compositions containing them
12/20/1995EP0687267A1 Pyrrolo-pyridine derivatives
12/20/1995EP0687265A1 Heterocyclic compounds and their preparation and use
12/20/1995EP0687251A1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists
12/20/1995EP0687249A1 Balanoids
12/20/1995EP0687180A1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens
12/20/1995EP0687178A1 Use of 2h-1,2,4-benzothiadiazine 3(4h)-one 1,1 dioxide derivatives as non-competitive nmda receptor antagonists
12/20/1995EP0605639B1 Air treatment plant for foodstuff comprising a trough with an adjustable width
12/20/1995EP0462258B1 Ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds
12/20/1995CN1113518A A novel peptide related to human programmed cell death and DNA encoding it
12/19/1995US5476966 Method for depletion of glutathione
12/19/1995US5476930 Thiophosphorylacetylamino linkage; reacting a thiophosphate compound with a bromoacetylamino compound
12/19/1995US5476874 New HIV protease inhibitors
12/19/1995US5476865 Methods of inhibiting bone loss
12/19/1995US5476858 Use of carbostyril to increase somatostatin or for inhibiting decrease of somatostatin to treat diseases related thereto
12/19/1995US5476857 Imidazopyridines
12/19/1995US5476856 Treatment of PAF and histamine-mediated diseases with 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
12/19/1995US5476855 Enzyme inhibitors, their synthesis and methods for use
12/19/1995US5476847 Treating cardiovascular, gastrointestinal, urogenital disorders
12/19/1995US5476846 Administering anti-thrombotic and anti-asthmatic agent
12/19/1995CA1337782C Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation
12/19/1995CA1337781C Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation
12/19/1995CA1337759C Glycopeptide antibiotic
12/18/1995CA2152023A1 Agents for treating metabolic bone diseases
12/14/1995WO1995033830A1 Bmp-9 compositions
12/14/1995WO1995033772A1 Flt4 receptor tyrosine kinase and its use in diagnosis and therapy
12/14/1995WO1995033762A1 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
12/14/1995WO1995033761A1 Steroid derivatives for treatment of 5 alpha reductase
12/14/1995WO1995033751A1 Bicycling lactam inhibitor of interleukin-1-beta converting enzyme
12/14/1995WO1995033743A1 Piperazine derivatives as 5ht1a antagonists
12/14/1995WO1995033727A1 Substituted pyrazoles having corticotropin-releasing factor (crf) antagonist activity
12/14/1995WO1995033721A1 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl)piperidines, tetrahydropyridines or piperazines
12/14/1995WO1995033712A1 Anti-inflammatory compounds
12/14/1995WO1995033709A1 Hydroxylamine derivatives and their use as metalloproteinase inhibiting agents
12/14/1995WO1995033486A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
12/14/1995WO1995033484A1 Method for treating and preventing atherosclerosis
12/14/1995WO1995033478A1 Acylated enol derivatives as prodrugs of elastase inhibitors
12/14/1995WO1995033466A1 Pyridylbisphosphonates for use as a therapeutical agent
12/14/1995WO1995033464A2 Retroviral protease inhibitor combinations
12/14/1995WO1995033461A1 Anti-inflammatory compounds
12/14/1995WO1995033455A1 Meta substituted arylalkylamines and therapeutic and diagnostic uses thereof
12/14/1995WO1995032190A3 Pharmaceutical diketopiperazine compounds
12/14/1995WO1995028426A3 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis
12/14/1995CA2192112A1 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl)piperidines, tetrahydropyridines or piperazines
12/14/1995CA2191996A1 Meta substituted arylalkylamines and therapeutic and diagnostic uses thereof
12/14/1995CA2191948A1 Retroviral protease inhibitor combinations
12/13/1995EP0686642A2 Modified guanidino and amidino thrombin inhibitors
12/13/1995EP0686629A2 Cyclohexyl tachykinine receptor antagonists
12/13/1995EP0686397A2 Use of chondroitin sulphate proteoglycans for protection of neurons
12/13/1995EP0686394A1 Use of N-[[5-(naphthales-1-yl)-1,3-dioxan-2-yl]alkyl]acetamide derivatives for the preparation of medicaments for use in the treatment of neurodegenerative disorders
12/13/1995EP0686194A1 Harp family growth factors, preparation methods therefor and uses thereof
12/13/1995EP0686156A1 Pyrazolitriazines with interleukin-1 and tumour necrosis factor inhibitory activity
12/13/1995EP0686151A1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
12/13/1995EP0686145A1 New compounds
12/13/1995EP0686144A1 New compounds
12/13/1995EP0686142A1 Polyamine derivatives as radioprotective agents
12/13/1995EP0686044A1 Inhibition of intimal hyperplasia using antibodies to pdgf receptors
12/13/1995EP0686040A1 Wound healing composition
12/13/1995EP0686038A1 Combination cisplatin/tamoxifen therapy for human cancers
12/13/1995EP0686037A1 Hormone replacement therapy
12/13/1995EP0686034A1 Bisacodyl dosage form
12/13/1995EP0470221B1 New arylethenylene derivatives and process for their preparation
12/13/1995CN1113236A Non-peptidyl tachykinin receptor antagonists
12/13/1995CN1113235A Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
12/13/1995CN1113142A Compositions based on-pyrones for inducing and stimulating hair growth and/or retarding hair loss, and use
12/12/1995US5475105 N-substituted azabicycloheptane derivatives
12/12/1995US5475104 Useful in magnetic resonance imaging; detection tumors, cancer cells; transition and lanthanide metals
12/12/1995US5475032 Treating strokes
12/12/1995US5475022 Treating acne
12/12/1995US5475006 Mixed oxidation products which cannot form Vitamin A
12/12/1995US5474996 Angiotension II inhibitors
12/12/1995US5474995 Phenyl heterocycles as cox-2 inhibitors
1 ... 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 ... 1564